Journey Medical Corporation/$DERM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Journey Medical Corporation
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Ticker
$DERM
Sector
Primary listing
Employees
58
Headquarters
Website
DERM Metrics
BasicAdvanced
$172m
-
-$0.37
1.04
-
Price and volume
Market cap
$172m
Beta
1.04
52-week high
$9.56
52-week low
$4.31
Average daily volume
232k
Financial strength
Current ratio
1.717
Quick ratio
1.38
Long term debt to equity
74.188
Total debt to equity
82.602
Interest coverage (TTM)
-1.71%
Profitability
EBITDA (TTM)
-2.021
Gross margin (TTM)
65.44%
Net profit margin (TTM)
-14.82%
Operating margin (TTM)
-9.80%
Effective tax rate (TTM)
-0.63%
Revenue per employee (TTM)
$1,120,000
Management effectiveness
Return on assets (TTM)
-4.49%
Return on equity (TTM)
-36.61%
Valuation
Price to revenue (TTM)
2.481
Price to book
5.54
Price to tangible book (TTM)
39.26
Price to free cash flow (TTM)
-23.947
Free cash flow yield (TTM)
-4.18%
Free cash flow per share (TTM)
-0.261
Growth
Revenue change (TTM)
15.00%
Earnings per share change (TTM)
-4.89%
3-year revenue growth (CAGR)
1.10%
3-year earnings per share growth (CAGR)
-44.41%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Journey Medical Corporation stock?
Journey Medical Corporation (DERM) has a market cap of $172M as of May 19, 2026.
What is the P/E ratio for Journey Medical Corporation stock?
The price to earnings (P/E) ratio for Journey Medical Corporation (DERM) stock is 0 as of May 19, 2026.
Does Journey Medical Corporation stock pay dividends?
No, Journey Medical Corporation (DERM) stock does not pay dividends to its shareholders as of May 19, 2026.
When is the next Journey Medical Corporation dividend payment date?
Journey Medical Corporation (DERM) stock does not pay dividends to its shareholders.
What is the beta indicator for Journey Medical Corporation?
Journey Medical Corporation (DERM) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.